Categories: International

AstraZeneca launches its patented life-saving heart drug BRILINTA® (Ticagrelor) in India

AstraZeneca Pharma India Limited (AZPIL) today announced the launch of a new patented antiplatelet drug BRILINTA® (Ticagrelor) in India. BRILINTA® is an oral antiplatelet treatment for Acute Coronary Syndromes (ACS) in adult patients. BRILINTA® is competitively priced to enable ACS patients benefit from having access to this medicine.

BRILINTA® works by preventing the formation of new blood clots and maintaining blood flow in the body to help reduce patient’s risk of another cardiovascular event (called atherothrombotic events) such as a heart attack or cardiovascular death.

The Drug Controller General of India (DCGI), based on the New Drug Advisory Committee’s (NDAC) recommendations granted its approval in May 2012 for marketing BRILINTA® (Ticagrelor) tablets in India.

The DCGI approval is based upon the submission of data from the landmark PLATO (Platelet Inhibition and Patient Outcomes) trial, comparing treatment with BRILINTA® to Clopidogrel – the current standard of care, available in the market for over a decade.

Dr. Paurus Irani, Vice President Medical & Regulatory Affairs of AstraZeneca Pharma India Limited said, “With over 40 lakh people affected by ACS in India each year, BRILINTA®gives cardiologists a new and effective treatment to help reduce the rate of heart attack and cardiovascular deaths in these patients. Such exciting medical breakthroughs don’t happen very often.”

To date, BRILINTA has been approved in 83 countries and launched in 63 countries (including India now) under the trade name BRILINTA® and in the European Union under the trade name BRILIQUE™.

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

2 days ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

2 days ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

3 days ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

3 days ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

4 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

4 days ago